BARCLAY ALEC (See Remarks) purchased 7.7% of their position (12.95K shares) of T2 BIOSYSTEMS, INC. on the open market
Open‑market purchase worth $6.5K — a moderate purchase. The strongest form of insider conviction signal.
P · 1 purchase
Filed: 4/11/2022ACC: 0000899243-22-014418
Officer· See Remarks
Since Jul 2018
+12.95K
Net shares
Net buyer
$6.5K
Total acquired
1
Open market trades
1B · 0S
1
Total transactions
12.95K acquired
Non-Derivative Transactions1
Common Stock
Direct
Shares
+12.95K
Price / share
$0.50
Trade value
$6.48K
% of position
7.7%
4/8/2022
168.99K→181.94K
Total
Net shares
+12.95K
Net value
$6.48K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 4/8/2022 | P · Purchase | +12.95K | $0.50 | $6.48K | 7.7% | 168.99K | 181.94K |
| Total | +12.95K | $6.48K | ||||||
Derivative Transactions0
No derivative transactions reported